FDA Approvals

Date Posted
Article Title
4/28/2010
4/13/2010
Pancreaze Approved for Lack of Pancreatic Enzymes

200,000 in U.S. need such products

4/8/2010
First Generic Versions of Cozaar and Hyzaar Approved

Drugs to treat high blood pressure

4/6/2010
Tougher-to-Abuse Form of OxyContin Approved

These pills are harder to cut and dissolve, maker says

4/5/2010
3/31/2010
Asclera Approved to Treat Varicose Veins

Improves appearance of swollen or twisted blood vessels

3/26/2010
Zyclara Approved to Treat Pre-Cancerous Skin Condition

Some 10 million Americans have actinic keratoses

3/25/2010
Xifaxan Approved for People With Liver Disease

To treat disorder that affects brain function

3/18/2010
Carbaglu Approved for Rare Genetic Disorder

Causes elevated ammonia in blood

3/17/2010
Implanted Hearing System Approved

To treat senorineural hearing loss

3/12/2010
Pelvic Artery Stent Approved

Props open vessel that supplies blood to the legs

3/9/2010
Botox Approved for Spasticity in Stroke Victims

A common aftereffect of stroke

3/4/2010
Heartburn Drug Kapidex Renamed to Dexilant

FDA approves name change to avoid confusion with other drugs

3/2/2010
Generic Flomax Approved for Enlarged Prostate

A common condition in older men

2/26/2010
2/24/2010
Successor to Combination Pneumococcal Vaccine Approved

Prevnar 13 offers broader protection against a host of bacterial diseases

2/24/2010
2/22/2010
2/19/2010
Rituxan Approved for Chronic Lymphocytic Leukemia

A cancer of the blood and bone marrow

2/11/2010